Alembic gets USFDA nod to market generic drugThe company has received tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) ...
20 Apr, 2022, 12.17 PM IST
Realisation there in pharma industry to become self reliant in API production: IPA"Reliance on China for APIs is there...We had the technology of making all kinds of APIs but over a period of time we lost that advantage. ...
25 Feb, 2021, 12.02 AM IST
Patanjali says in “complete compliance of laws”; denies receiving notice from USFDAMedia reports earlier this week said labels on Patanjali's two sharbat products, earmarked to be sold within India, were found to be having...
23 Jul, 2019, 02.23 PM IST
The curious case of USFDA observations and skyrocketing stock pricesUS FDA investigation and observations have material impact on stock prices.
05 Mar, 2018, 12.37 PM IST
Sun Pharma shares set to extend losses for fourth day on rising concern over Halol facilityETNow on Tuesday reported that the USFDA has informed that the Halol facility has issued a 14-page Form 483 post inspection.
07 Dec, 2016, 12.31 PM IST
Zydus Cadila gets USFDA nod for diabetes treatment drugZydus Cadila has received final approval from the US health regulator to market Nateglinide tablets, used for treatment of diabetes.
11 Jul, 2016, 12.14 PM IST
Zydus Cadila gets USFDA's final nod for fungal treatment drugShares of Cadila Healthcare, the group's listed entity, were trading 0.41 per cent up at Rs 319.45 on BSE in the afternoon session.
25 May, 2016, 01.19 PM IST
Zydus Cadila gets USFDA nod to sell generic diabetes drugThe group has received final approval from USFDA to market the drug in strengths of 1.25, 2.5 and 5 mg, Zydus Cadila said in a statement.
11 May, 2016, 01.32 PM IST
Wockhardt slips 11% on USFDA concerns, down 29% in 4 sessionsThe stock fell 11.02 per cent to hit a low of Rs 1,146.40.
18 Jan, 2016, 10.50 AM IST
Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
06 Jan, 2016, 06.51 PM IST
Ipca Lab shares tank 13.5%; m-cap down Rs 1,381 croreShares of Ipca Laboratories today fell sharply by 13 per cent as the company voluntarily stopped active pharmaceutical ingredients (API) sh...
24 Jul, 2014, 06.18 PM IST
Do not support sabotage theory for Toansa plant: RanbaxyRejecting sabotage theory at Toansa plant that faces USFDA ban, Ranbaxy denied blaming company's voluntary retirement scheme for problems i...
11 Feb, 2014, 06.19 PM IST
USFDA finds company's SEZ Indore unit acceptable: Ipca LabsThis will enable the company to commercialise oral solid dosage formulations in the US market from this manufacturing facility.
04 Sep, 2013, 02.07 PM IST
Is it time to start buying beaten down Wockhardt?Shares of Wockhardt have been beaten down badly after the company received a warning by the USFDA.
29 May, 2013, 12.30 PM IST
- Lupin eyes $150 mn from oral contraceptives in US by FY14
Drug firm Lupin is expecting revenues of up to USD 150 million (over Rs 780 crore) from its oral contraceptive (OC) segment in the US marke...
27 Nov, 2011, 01.42 PM IST
- Aurobindo to suffer $2-mn loss per month due to USFDA ban
Aurobindo Pharma said they may incur a revenue loss to the extent of $2 million per month till the issue remains unresolved.
24 Feb, 2011, 06.53 PM IST
- Orchid gets US nod for new drug
Orchid Chemicals and Pharmaceuticals Ltd has received approval from USFDA for three of its Abbreviated New Drug Applications (ANDAs) for Ce...
16 Aug, 2006, 11.50 AM IST